Although there is biological evidence, the clinical impact of M2-TAM’s pro-tumor activity and via STAT3 and NF-κB signaling pathways on the overall survival of cervical cancer patients has not been clarified. The gene discussed is NFKB1; the disease is cervical carcinoma.